Correction to: Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis
Crossref DOI link: https://doi.org/10.1007/s00535-022-01910-7
Published Online: 2022-08-03
Published Print: 2022-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhou, Qunfang http://orcid.org/0000-0002-2533-3851
Wang, Xiaohui
Li, Ruixia
Wang, Chenmeng
Wang, Juncheng
Xie, Xiaoyan
Li, Yali
Li, Shaoqiang
Mao, Xianhai
Liang, Ping
Text and Data Mining valid from 2022-08-03
Version of Record valid from 2022-08-03
Article History
First Online: 3 August 2022